Artemis Medicare Services Limited — PPTs, 15-11-2024: Investor Presentation

**Financial Highlights:** Artemis Medicare Services has reported strong financial performance for Q2 FY25 and H1 FY25, achieving the highest revenue and EBITDA margins to date. Gross revenue for Q2 FY25 reached ₹2,523 Mn, up 6.2% year-on-year, while net revenue was ₹2,414 Mn, showing a 7.3% increase. EBITDA rose significantly to ₹497 Mn, with a margin of 20.6%. For H1 FY25, total income climbed to ₹4,765 Mn, reflecting an 8.7% increase compared to the prior half-year.

**Strategic Initiatives and Growth Drivers:** The company has inaugurated a third hospital tower, increasing bed capacity to over 700. This move aims to improve economies of scale and operational efficiency. Artemis has also gained board approval for a long-term agreement to manage a new 300+ bed super-speciality hospital in Raipur, set to enhance regional reach.

**Business Developments:** The emphasis on international patient care is significant, with robust revenue contributions from this segment, further bolstering Artemis’s reputation as a leading medical tourism destination.

**Market Position and Competitive Advantage:** With a diversified service offering across multiple specialties and a strong base of over 500 full-time doctors, Artemis hospitals maintain a competitive edge. The continuous upgrade of facilities and accreditations support its status as a premier healthcare provider in Delhi NCR.

**Investor Implications:** The ongoing expansion and strong operational metrics suggest a positive outlook for Artemis, making it an attractive prospect for investors. The strategic focus on higher-value segments and international patient inflow presents opportunities for continued growth, while operational improvements mitigate risks.